Table 1 Demographics of patients with relapsing primary central nervous system lymphoma
Number: 37 | |
|---|---|
Variables | |
Median age in years at diagnosis (Min, Max) | 63.7 (27.6, 80.1) |
Gender (N, % Female) | 21 (57%) |
Median KPS at diagnosis (Min, Max) | 80 (20, 100) |
Ocular involvement (%) | 7 (18.9%) |
Treatment regiment | HD-MTX/BBBD without rituximab: 30 (81.1%) |
HD-MTX/BBBD with rituximab: 7 (18.9%) | |
Median age in years at relapse (Min, Max) | 65.1 (31.6, 80.8) |
Median time to progression in months | 17.8 (95% CI 11.7–41.7) |